Chuqi Lei
Beijing, 100020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.
Journal: Mediators of inflammation
Published: October 29, 2025
Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.
Journal: Mediators of inflammation
Published: October 29, 2025
Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.
Journal: Mediators of inflammation
Published: October 29, 2025
SERPINA1 gene regulates the tumorigenesis and progression of breast cancer through PI3K/AKT signaling pathway and tumor immune microenvironment.
Journal: Scientific reports
Published: March 29, 2025
Unraveling breast cancer prognosis: a novel model based on coagulation-related genes.
Journal: Frontiers in molecular biosciences
Published: March 01, 2024
PD-1/PD-L1 Inhibitor - Related Adverse Events and Their Management in Breast Cancer.
Journal: Journal of Cancer
Published: April 19, 2023
AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer.
Journal: Frontiers in oncology
Published: March 29, 2023
ST6GALNAC1 promotes the invasion and migration of breast cancer cells via the EMT pathway.
Journal: Genes & genomics
Published: January 27, 2023
Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume II.
Journal: Frontiers in pharmacology
Published: January 03, 2023
Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004).
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: March 12, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026